Videos | Coronavirus (COVID-19)

Aaron Baggish, M.D., director of the cardiovascular performance program, Mass General Hospital, has been involved in the ...

Home January 20, 2022
Home
Arineta created a dedicated cardiac CT scanner in partnership with GE Healthcare a couple years ago. With increased interest in CTA with the new chest pain guidelines, the company decided to also start direct sales of these systems for the first time at RSNA in their own booth. Photos by Dave Fornell
Feature | RSNA | By Dave Fornell, DAIC Editor

Here are a few of the key takeaways on the new technologies that will impact cardiovascular and interventional medicine ...

Home January 19, 2022
Home
News | Coronavirus (COVID-19)

January 19, 2022 — Heart function recovery returned within three months in children who developed COVID-19 related multi ...

Home January 19, 2022
Home
Videos | Magnetic Resonance Imaging (MRI)

Orlando Simonetti, Ph.D., professor, cardiovascular medicine, worked with Siemens to help develop a new, lower-field ...

Home January 18, 2022
Home
News | Structural Heart

January 18, 2022 — Peregrine Ventures, a leading investment firm dedicated to supporting life changing healthcare ...

Home January 18, 2022
Home
Case Study | Cardiovascular Information Systems (CVIS)

Health systems are recognizing that aggregated cardiac imaging data is an asset rather than a liability. Disparate ...

Home January 18, 2022
Home
News | Cath Lab Navigation Aids

January 18, 2022 – Philips Healthcare announced physicians will now have access to advanced new 3D image guidance ...

Home January 18, 2022
Home
Blog | Heart Failure

After 15 years of covering new cardiovascular technologies, it is not often that something comes across my email, or I ...

Home January 17, 2022
Home
News | Peripheral Artery Disease (PAD)

January 17, 2022 – The Vascular Care Group (TVCG) announced Stephen J. Hoenig M.D., successfully completed a ...

Home January 17, 2022
Home
News | Structural Heart

January 17, 2022 – As the increasing number of structural heart interventions are assisted by real-time imaging guidance ...

Home January 17, 2022
Home
News | EP Lab

January 14, 2022 — Medtronic has entered into a definitive agreement to acquire Affera Inc., a Boston area-based ...

Home January 14, 2022
Home
A new treatment to achieve return of spontaneous circulation (ROSC) in refractory cardiac arrest patients is the use of resuscitative endovascular balloon occlusion of the aorta (REBOA). The images show the balloon seen deployed on an angiogram and an illustration showing its placement in the aorta. 
Feature | Sudden Cardiac Arrest | By Adam Power, M.D.

Out-of-hospital cardiac arrest (OHCA) continues to be overwhelmingly fatal despite cardiopulmonary resuscitation (CPR) ...

Home January 14, 2022
Home
Videos | Artificial Intelligence

Here are two examples of artificial intelligence (AI) driven pulmonary embolism (PE) response team apps featured by ...

Home January 13, 2022
Home
Sponsored Content | Videos | Cath Lab

Advancements in analytics and data visualizations are helping to streamline operations and improve productivity at cath ...

Home January 13, 2022
Home
News | EP Lab

January 13, 2022 — Abbott received U.S. Food and Drug Administration (FDA) clearance for the EnSite X EP System with ...

Home January 13, 2022
Home
Subscribe Now